Accuray President and Chief Executive Officer Suzanne Winter Returns from Medical Leave of Absence

15.10.24 14:45 Uhr

Werte in diesem Artikel
Aktien

1,71 EUR 0,00 EUR 0,00%

MADISON, Wis., Oct. 15, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced that, effective as of today, Suzanne Winter has returned from her temporary medical leave and assumed her full duties as President and Chief Executive Officer. Sandeep Chalke, who has served as interim CEO during Ms. Winter's absence, will continue in his position as Senior Vice President and Chief Commercial Officer.

Accuray Incorporated (PRNewsFoto/Accuray Incorporated) (PRNewsFoto/Accuray Incorporated)

"On behalf of the entire Board of Directors, I am delighted Suzanne has resumed her role as CEO. We appreciate the leadership provided by Sandeep in her absence and the support of the global Accuray team," said Joseph Whitters, Chairman of the Board at Accuray.

About Accuray
Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions designed to deliver radiation treatments for even the most complex cases—while making commonly treatable cases even easier—to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in Madison, Wisconsin, with facilities worldwide. To learn more, visit www.accuray.com or follow us on Facebook, LinkedIn, X, and YouTube.

Investor Contact
Aman Patel, CFA
Investor Relations, ICR-Westwicke
+1 (443) 450-4191
aman.patel@westwicke.com

Media Contact
Beth Kaplan
Public Relations Director, Accuray
+1 (408) 789-4426
bkaplan@accuray.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/accuray-president-and-chief-executive-officer-suzanne-winter-returns-from-medical-leave-of-absence-302276241.html

SOURCE Accuray Incorporated

Ausgewählte Hebelprodukte auf Accuray

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Accuray

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu Accuray IncShs

Analysen zu Accuray IncShs

DatumRatingAnalyst
30.11.2017Accuray BuyLake Street
22.12.2015Accuray Sector PerformRBC Capital Markets
01.05.2015Accuray BuyDougherty & Company LLC
12.01.2015Accuray OutperformNorthland Capital
06.11.2007Accuray günstig bewertetGlobal Biotech Investing
DatumRatingAnalyst
30.11.2017Accuray BuyLake Street
01.05.2015Accuray BuyDougherty & Company LLC
12.01.2015Accuray OutperformNorthland Capital
06.11.2007Accuray günstig bewertetGlobal Biotech Investing
DatumRatingAnalyst
22.12.2015Accuray Sector PerformRBC Capital Markets
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Accuray IncShs nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"